Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Brain : a Journal of Neurology|August 12, 2024
JC virus spread is potentiated by glial replication and demyelination-linked glial proliferationCui Li, Nguyen P T Huynh, Steven J Schanz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 28, 2014
A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human gliaMartha S Windrem, Steven J Schanz, Carolyn Morrow, et al.
Glia|November 5, 2022
Glial progenitor cells of the adult human white and grey matter are contextually distinctMaria Joana Osorio, John N Mariani, Lisa Zou, et al.
Nature Biotechnology|September 28, 2011
CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cellsFraser J Sim, Crystal R McClain, Steven J Schanz, et al.
Cell Reports|May 21, 2020
Human Glial Progenitor Cells Effectively Remyelinate the Demyelinated Adult BrainMartha S Windrem, Steven J Schanz, Lisa Zou, et al.
Nature Communications|April 23, 2026
Charting the transition from in vitro gliogenesis to the in vivo maturation of human glial progenitor cells transplanted into the hypomyelinated mouse brainJohn N Mariani, Steven J Schanz, Benjamin Mansky, et al.
Cell Stem Cell|June 5, 2008
Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouseMartha S Windrem, Steven J Schanz, Min Guo, et al.
The Journal of Clinical Investigation|November 18, 2014
Human glial chimeric mice reveal astrocytic dependence of JC virus infectionYoichi Kondo, Martha S Windrem, Lisa Zou, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
In vivo selection and glymphatic delivery of AAV5 capsids engineered to target human glial progenitor cellsAlexander Cona, Evan Newbold, Deniz Kesmen, et al.
Nature Biotechnology|July 8, 2026
Efficient targeting of human glial progenitor cells in vivo with engineered AAV vectors and glymphatic deliveryAlexander Cona, Evan Newbold, Deniz Kesmen, et al.
Pageof 1